Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (1031-1040 of 1,306) with videos related to

Pageof 131
Sort By:
JAMA Network Open|October 16, 2025
Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department: A Randomized Clinical TrialMia T Minen, Elizabeth K Seng, Benjamin W Friedman, et al.
Journal of Medical Economics|May 8, 2013
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UKAnthony J Batty, Ryan N Hansen, Lisa M Bloudek, et al.
Neurology|March 8, 2013
Screening for predementia AD: time-dependent operating characteristics of episodic memory testsCarol A Derby, Leah C Burns, Cuiling Wang, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Annals of Emergency Medicine|April 5, 2008
Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomesBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Cephalalgia : an International Journal of Headache|August 28, 2023
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trialRichard B Lipton, Rashmi B Halker Singh, Laszlo Mechtler, et al.
Headache|January 23, 2018
Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO StudyDawn C Buse, Scott W Powers, Amy A Gelfand, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.
Diabetes Care|January 29, 2011
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetesSiri Atma W Greeley, Priya M John, Aaron N Winn, et al.
Pageof 131

Showing results (1031-1040 of 1,306) with videos related to

Sort By:
Pageof 131
JAMA Network Open|October 16, 2025
Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department: A Randomized Clinical TrialMia T Minen, Elizabeth K Seng, Benjamin W Friedman, et al.
Journal of Medical Economics|May 8, 2013
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UKAnthony J Batty, Ryan N Hansen, Lisa M Bloudek, et al.
Neurology|March 8, 2013
Screening for predementia AD: time-dependent operating characteristics of episodic memory testsCarol A Derby, Leah C Burns, Cuiling Wang, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Annals of Emergency Medicine|April 5, 2008
Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomesBenjamin W Friedman, Michael L Hochberg, David Esses, et al.
Cephalalgia : an International Journal of Headache|August 28, 2023
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trialRichard B Lipton, Rashmi B Halker Singh, Laszlo Mechtler, et al.
Headache|January 23, 2018
Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO StudyDawn C Buse, Scott W Powers, Amy A Gelfand, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.
Diabetes Care|January 29, 2011
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetesSiri Atma W Greeley, Priya M John, Aaron N Winn, et al.
Pageof 131